Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - HUMAN GENOME SCIENCES INC | c15531exv99w1.htm |
| EX-99.2 - EXHIBIT 99.2 - HUMAN GENOME SCIENCES INC | c15531exv99w2.htm |
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 14, 2011
HUMAN GENOME SCIENCES,
INC.
(Exact name of registrant as
specified in its charter)
| Delaware | 001-14169 | 22-3178468 | ||
| (State or other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
| 14200 Shady Grove Road,
Rockville, Maryland |
20850-7464 | |
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: (301) 309-8504
| (Former name or former address if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01. Regulation FD Disclosure.
On April 14, 2011, the Company issued the press release attached as Exhibit 99.1 to this Form 8-K, which includes Company guidance regarding 2011 year-end cash, 2011 selling, general & administrative expense and research & development expense and the Company’s expectation for achievement of profitability.
On April 14, 2011, representatives of the Company will host an Analyst & Investor Meeting beginning at 1:00 pm Eastern Time. The meeting will be webcast and may be accessed at www.hgsi.com. During this meeting, the Company will present the slides attached as Exhibit 99.2 to this Form 8-K.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
99.1 Press Release, dated April 14, 2011.
99.2 Slide Presentation, dated April 14, 2011.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
HUMAN GENOME SCIENCES, INC.
| By: | /s/ James H. Davis, Ph.D. | |
| Name: James H. Davis, Ph.D. Title: Executive Vice President, General Counsel and Secretary |
Date: April 14, 2011
INDEX TO EXHIBITS
| Exhibit No. | Description | |
|
99.1
|
Press Release, dated April 14, 2011. | |
|
99.2
|
Slide Presentation, dated April 14, 2011. | |